The diagnostics technology developer picked up Jemincare and Haier Biomedical for its second funding round since spinning off from parent company 3D Medicines in 2018.

China-based medical test developer 3DMed Diagnostic has closed a RMB1.5bn ($224m) funding round featuring pharmaceutical firm Jemincare and biomedical cold chain storage provider Haier Biomedical, DealStreetAsia has reported.

The round was led by CPE, the alternative asset management arm of state-owned investment firm Citic Group, and included CICC Capital, a private equity arm of investment bank China International Capital Corporation.

The state-owned Spinnotec filled out the round alongside Shandong Transportation Industrial Development Fund, Luxin Venture Capital, Sangel Capital, Ruiyi Investment…